Technical analyst Anil Singhvi is bullish on Fortis Healthcare Ltd and has recommended 'buy' rating on the stock with a target of Rs 200.

According to analyst, the interested investors can buy the stock with a stop loss of Rs 150.

Mr. Singhvi added that the investors can achieve the said target within a period of 30-45 days.

The stock of the company, on Nov 22, closed at Rs 152.15 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 104 on BSE.

Current EPS & P/E ratio stood at 2.70 and 56.37 respectively.

Fortis Healthcare has posted around six-fold increase in its consolidated net profit, which stood at Rs 74.78 crore for the three month period ended September 30.

The company said that its profit came up through its stake sell in Singapore-based hospital chain Parkway.

The company has a net profit of Rs 12.97 crore during the same period of last year.

The company recorded a profit of Rs 53.9 crore in the second quarter of 2010 when it disinvested its 25.37% equity stake in Parkway.

In July 2010, Fortis backed out from the race to get hold of a controlling equity stake in Parkway Holdings, a Singapore-based hospital chain.

The company's total income surged to Rs 357.86 crore in July-September quarter as against Rs 190.49 crore in the same period of 2009.